Table 1.

Characterization of the ALS patient cohort.

Characterization of patient cohort	ALS patients (n = 117)
Onset (spinal: bulbar), N (%)	96: 21 (82%: 18%)
UMN dominant: LMN dominant: UMN/LMN equally, N (%)	14: 83 :19 (12%: 71%: 16%)
Disease duration, median (Q25, Q75)	17 months (11 months; 25 months)
ALSFRS-R, median (Q25, Q75)	40 (35.25; 43)
ALSFRS-R decline per month, progression rate, mean (sd)	0,91 (0,89)

ALSFRS-R: Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised, sd: standard deviation, Q: Quartile